Spots Global Cancer Trial Database for her2+ advanced breast cancer
Every month we try and update this database with for her2+ advanced breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors | NCT06027983 | HER2+ Advanced ... Other Solid Tum... | Chimeric recept... Fludarabine and... | 21 Years - 99 Years | National University Hospital, Singapore |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
